{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:40:08Z","timestamp":1756370408077,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,7,20]]},"abstract":"<jats:p>Cerebral venous thrombosis (CVT) is an uncommon disorder associated with diverse processes. We report a patient who, while receiving desmopressin and contraceptive pills (OCP), developed straight sinus thrombosis. Clinical assessment and laboratory investigations revealed untreated hyperthyroidism and a hypercoagulable state, characterised by high levels of von Willebrand factor, factor VIII coagulant activity and IgM cardiolipin antibody. The clinical picture improved with anticoagulation, treatment of hyperthyroidism and discontinuation of OCP and desmopressin. To the best of our knowledge, the association between the use of oral desmopressin and CVT has not been described. The multiple risk factors present in our case were probably additive in increasing the risk of CVT. Although this case represents a rare occurrence, practitioners should be alerted to the possible associations of desmopressin, oral contraceptives and Graves' disease with venous thrombosis.<\/jats:p>","DOI":"10.1136\/bcr-2016-216584","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T13:44:00Z","timestamp":1470663840000},"page":"bcr2016216584","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Cerebral venous thrombosis associated with thyrotoxicosis, the use of desmopressin and elevated factor VIII\/von Willebrand factor"],"prefix":"10.1136","volume":"2016","author":[{"given":"Waqar","family":"Waheed","sequence":"first","affiliation":[{"name":"Department of Neurological Sciences, University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Aljerdi","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Decker","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W","family":"Hamill","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.067835"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia treated with DDAVP","volume":"318","author":"Bond","year":"1988","journal-title":"N Engl J Med"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.4","first-page":"49","article-title":"Venous thrombosis of the lower limbs and pulmonary embolism after desmopressin: a coincidence or a pathogenetic role","volume":"139","author":"Pentimone","year":"1991","journal-title":"Clin Ter"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830280115"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.607"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09134.x"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.8","doi-asserted-by":"publisher","DOI":"10.1159\/000087717"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.9","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055811.05743.10"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.12.3067"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.11","first-page":"270","article-title":"Case of cerebral venous thrombosis due to Graves\u2019 disease with increased factor VIII activity","volume":"46","author":"Kasuga","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1445-5994.1984.tb03622.x","article-title":"Autoimmune thyroid disease and giant cell arteritis: a review, case report and epidemiological study","volume":"14","author":"Nicholson","year":"1984","journal-title":"Aust N Z J Med"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.13","first-page":"806","article-title":"A case of Graves\u2019 disease associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries","volume":"93","author":"Liu","year":"1994","journal-title":"J Formos Med Assoc"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.318.7181.434","article-title":"Giant cell arteritis and thyroid dysfunction: multicenter case-control study. The Groupe de Recherche sur l'Arteritea Cellules Geantes","volume":"318","author":"Duhaut","year":"1999","journal-title":"BMJ"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra002974"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.16","first-page":"624152","article-title":"Graves\u2019 disease associated with cerebrovascular disease and antiphospholipid antibody syndrome","volume":"2010","author":"Khochtali","year":"2010","journal-title":"J Endocrinol"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.17","doi-asserted-by":"crossref","unstructured":"Janovsky CC , Fukuda TG , Silva GS , et al . An unusual association between acute ischaemic stroke and cerebral venous thrombosis with thyrotoxic state. BMJ Case Rep 2013; doi:10.1136\/bcr-2013-201130 doi:10.1136\/bcr-2013-201130","DOI":"10.1136\/bcr-2013-201130"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.18","doi-asserted-by":"publisher","DOI":"10.1177\/096120339400300401"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.19","first-page":"1393","article-title":"A family study of the antiphospholipid syndrome associated with other autoimmune diseases","volume":"19","author":"Dagenais","year":"1992","journal-title":"J Rheumatol"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.20","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1360001"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92560-0"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0085-5"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.103465"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1055\/s-0037-1614323","article-title":"Venous thrombosis, oral contraceptives and high factor VIII levels","volume":"82","author":"Bloemenkamp","year":"1999","journal-title":"Thromb Haemost"},{"key":"2025082801272820000_2016.aug08_1.bcr2016216584.26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1160\/TH04-04-0251","article-title":"The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism","volume":"93","author":"Tirado","year":"2005","journal-title":"Thromb Haemost"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-216584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:27:39Z","timestamp":1756369659000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-216584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":26,"alternative-id":["10.1136\/bcr-2016-216584"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-216584","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}